| 1. |
2024
Suk FM ,Hsu FY,Hsu MH,Chiu WC,Fang CC,Chen TL, Liao YJ*.
Treatment with a new barbituric acid derivative suppresses diet-induced metabolic dysfunction and non-alcoholic fatty liver disease in mice
. Life Sciences
.2024
;(336)
|
|
| 2. |
2024
Hsu FY,Yang SC,Suk FM, Hitoshi Shirakawa,Chiu WC* ,Liao YJ*.
Dietary rice bran attenuates hepatic stellate cell activation and liver fibrosis in mice through enhancing antioxidant ability
. The Journal of Nutritional Biochemistry
.2024
;(125)
|
|
| 3. |
2024
Shih MS,Suk FM,Chiu WC,Lee CY,Hsu FY,Liao YJ*.
Long-term di-(2-ethylhexyl) phthalate exposure reduces sorafenib treatment efficacy by enhancing mesenchymal transition in hepatocellular carcinoma
. Ecotoxicology and Environmental Safety
.2024
;(273)
|
|
| 4. |
2023
Suk FM ,Hsu FY,Lee YC,Chen TL,Chiu WC ,Liao YJ*.
Dietary oxidized frying oil activates hepatic stellate cells and accelerates the severity of carbon tetrachloride- and thioacetamide-induced liver fibrosis in mice
. Journal of Nutritional Biochemistry
.2023
;(115):1-9
|
|
| 5. |
2023
Suk FM ,Wu CY,Fang CC,Chen TL,Liao YJ*.
β-HB treatment reverses sorafenib resistance by shifting glycolysis–lactate metabolism in HCC
. Biomedicine & Pharmacotherapy
.2023
;(166)
|
|
| 6. |
2023
Liao YJ,Lee CY,Twu YC,Suk FM,Lai TC,Chang YC, Lai YC, Yuan JW, Jhuang HM, Jian HR, Huang LC, Chen KP*, Hsu MH*.
Isolation and Biological Evaluation of Alfa-Mangostin as Potential Therapeutic Agents against Liver Fibrosis
. Bioengineering
.2023
;(10)
|
|
| 7. |
2022
Suk FM ,Wu CY,Chiu WC ,Chien CY,Chen TL,Liao YJ*.
HMGCS2 Mediation of Ketone Levels Affects Sorafenib Treatment Efficacy in Liver Cancer Cells
. molecules
.2022
;(27):1-15
|
|
| 8. |
2021
Liao YJ*, Wang YH, Wu CY, Hsu FY, Chien CY, Lee YC .
Ketogenic Diet Enhances the Cholesterol Accumulation in Liver and Augments the Severity of CCl4 and TAA-Induced Liver Fibrosis in Mice
. Int. J. Mol. Sci.
.2021
;(22):1-15
|
|
| 9. |
2021
Wu YX, Lu HF, Lin YH, Chuang HY, Su SC*, Liao YJ*, Twu YC* .
Branched I antigen regulated cell susceptibility against natural killer cytotoxicity through its N-linked glycosylation and overall expression
. Glycobiology
.2021
;(31):624-635
|
|
| 10. |
2021
Suk FM ,Wang YH,Chiu WC ,Liu CF ,Wu CY ,TL Chen, YJ Liao*.
Secretory NPC2 Protein-Mediated Free Cholesterol Levels Were Correlated with the Sorafenib Response in Hepatocellular Carcinoma.
. International journal of molecular sciences
.2021
;(22):1-15
|
|
| 11. |
2020
Wang YH,Suk FM,Liu CL,Chen TL,Twu YC,Hsu MM, Liao YJ.
Antifibrotic Effects of a Barbituric Acid Derivative on Liver Fibrosis by Blocking the NF-kB Signaling Pathway in Hepatic Stellate Cells
. Frontiers in Pharmacology
.2020
;(11):1-15
|
|
| 12. |
2020
Lee CY,Suk FM,YC Twu,Liao YJ*.
Long-Term Exposure to Low-Dose Di-(2-ethylhexyl) Phthalate Impairs Cholesterol Metabolism in Hepatic Stellate Cells and Exacerbates Liver Fibrosis
. Int. J. Environ. Res. Public Health
.2020
;(17):1-13
|
|
| 13. |
2020
Liao YJ ,Hsu SM ,Chien CY ,Wang YH ,Hsu MH *,Suk FM *.
Treatment with a New Barbituric Acid Derivative Exerts Antiproliferative and Antimigratory Effects Against Sorafenib Resistance in Hepatocellular Carcinoma.
. Molecules
.2020
;(25):1-17
|
|
| 14. |
2020
Wang YH,Suk FM,Liao YJ*.
Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
. Cancers
.2020
|
|
| 15. |
2020
Yang CY,Fan MH,Miao CH,Liao YJ,Yuan RH,Liu CL.
Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer
. Molecular Therapy Oncolytics
.2020
|
|
| 16. |
2020
Chen YJ,Liao YJ , Ngoc VT Tram,Lin CH,Liao KC,Liu CL.
Alterations of Specific Lymphocytic Subsets with Aging and Age-Related Metabolic and Cardiovascular Diseases.
. Life
.2020
;(246)
|
|
| 17. |
2020
Liao YJ ,Wang YH,Liu CL,Fang CC,Hsu MH*,Suk FM*.
4-Methoxy Sulfonyl Paeonol Inhibits Hepatic Stellate Cell Activation and Liver Fibrosis by Blocking the TGF-β1/Smad, PDGF-BB/MAPK and Akt Signaling Pathways
. Applied Sciences
.2020
|
|
| 18. |
2019
Chen JC,Chuang HY,Liao YJ,Hsu FT,Chen YC,Wang WH, Hwang JJ..
Enhanced cytotoxicity of human hepatocellular carcinoma cells following pretreatment with sorafenib combined with trichostatin A.
. Oncol Lett.
.2019
;(17):638-645
|
|
| 19. |
2019
Mao TL,Miao CH,Liao YJ,Chen YJ,Yeh CY,Liu CL.
Ex Vivo Expanded Human Vγ9Vδ2 T-Cells Can Suppress Epithelial Ovarian Cancer Cell Growth
. Int J Mol Sci.
.2019
;(20):1139--1149
|
|
| 20. |
2019
Suk FM,Liu CL,Hsu MH,Chuang YT,Wang P,Liao YJ.
Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinoma
. Scientific reports
.2019
;(9):1-10
|
|
| 21. |
2019
Wang YH,Liu CL,Chiu WC,Twu YC, Liao YJ.
HMGCS2 Mediates Ketone Production and Regulates the Proliferation and Metastasis of Hepatocellular Carcinoma
. cancers
.2019
;(11):1-18
|
|
| 22. |
2018
Chin-Han Huang,Yi-Jen Liao,Ting-Hsi Fan,Tzeon-Jye Chiou,Yen-Hsi Lin,Yuh-Ching Twu.
A Developed NK-92MI Cell Line with Siglec-7neg Phenotype Exhibits High and Sustainable Cytotoxicity against Leukemia Cells
. Int. J. Mol. Sci.
.2018
;(19):1073-1087
|
|
| 23. |
2018
AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage
. Scientific Reports
.2018
;(14)
|
|
| 24. |
2018
Wang YH,Twu YC,Wang CK,Lin FZ,Lee CY,Liao YJ.
Niemann-Pick Type C2 Protein Regulates Free Cholesterol Accumulation and Influences Hepatic Stellate Cell Proliferation and Mitochondrial Respiration Function
. Int J Mol Sci.
.2018
;(19): 1-15
|
|
| 25. |
2017
Yen CH,Lai CC,Liao CC,Wang SF,Liao YJ,Tung CY, Hung SF, Chen YM.
Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development
. Scientific Report
.2017
;(7):3052
|
|
| 26. |
2017
Yu CY,Chou WT,Liao YJ,Lee JH,Liang JA,Hsu SM.
Impact of radiation attenuation by a carbon fiber couch on patient dose verification
. Sci Rep
.2017
;(7):43336
|
|
| 27. |
2017
Hsu MH,Hsu SM,Kuo YC,Liu CY,Hsieh CY,Twu YC, Wang CK, Wang YH, Liao YJ*.
Treatment with low-dose sorafenib in combination with a novel benzimidazole derivative bearing a pyrolidine side chain provides synergistic antiproliferative effects against human liver cancer
. RSC Advances
.2017
;(7):16253-16263
|
|
| 28. |
2017
Lee YH,Liao YJ,Huang CH,Chang FL,Fan TH,Twu YC.
Branched I antigens on leukemia cells enhanced sensitivity against natural killer–cell cytotoxicity through affecting the target–effector interaction
. Transfusion
.2017
;(57):1040-1051
|
|
| 29. |
2017
Hsu SM,Hung CH,Liao YJ,Fu HM,Tsai JT,Huang YH, Huang David YC*.
Feasibility Study on Applying Radiophotoluminescent Glass Dosimeters for CyberKnife SRS Dose Verification
. PLoS One
.2017
;(12):e01692
|
|
| 30. |
2016
Hsu SM,Wang SF,Hsieh YJ,Cheng CC,Liao YJ.
The Physical and Biomedical Characteristics of the Novel Transmission Type X-ray Equipment
. Radiation measurements
.2016
;(90):238-241
|
|
| 31. |
2016
Chuang H,Huang LC,Kapoor M,Liao YJ,Yang CL,Chang CC, Wu CY, Hwu JR, Huang TJ and Hsu MH.
Design and synthesis of pyridine-pyrazole-sulfonate derivatives as potential anti-HBV agents.
. MedChemComm
.2016
;(7):832-836
|
|
| 32. |
2016
Twu YC,Lee TS,Hsu SM,Wang YH,Liao CY,Wang CK, Liang YC, Liao YJ*..
Niemann-Pick type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation
. International journal of molecular sciences
.2016
;(17):1122
|
|
| 33. |
2016
Liao YJ,Lee TS,Twu Y,Hsu SM,Yang CP,Wang CK, Liang YC, Chen YM*..
Glycine N-methyltransferase deficiency in female mice impairs insulin signaling and promotes gluconeogenesis by modulating the PI3K/Akt pathway in the liver.
. Journal of Biomedical Science
.2016
;(23):69-77
|
|
| 34. |
2016
Liao YJ,Lee YH,Chang FL,Ho H,Huang CH,Twu YC*.
The SHP-2-ERK2 signaling pathway regulates branched I antigen formation by controlling the binding of C/EBPα to the IGnTC promoter region during erythroid differentiation.
. Transfusion
.2016
|
|
| 35. |
2016
Wu CH,Liao YJ,Lin TY,Chen YC,Sun SS,Liu YWH, Hsu SM.
A Volume-Equivalent Spherical Necrosis-Tumor-Normal Liver Model for Estimating Absorbed Dose in Yttrium-90 Microsphere Therapy
. MEDICAL PHYSICS
.2016
|
|
| 36. |
2015
Lee JH,Chang LT,Shiau AC,Chen CW,Liao YJ,Li WJ, Lee MS, Hsu SM.
A Novel Simple Phantom for Verifying the Dose of Radiation Therapy
. J. Biomedicine and Biotechnology
.2015
|
|
| 37. |
2015
Liao YJ,Fang CC,Yen CH,Hsu SM,Wang CK,Huang SF, Liang YC, Lin YY, Chu YT and Chen YM.
Niemann-Pick type C2 protein regulates liver cancer progression via modulating ERK1/2 pathway: Clinicopathological correlations and therapeutical implications
. international journal of cancer
.2015
|
|
| 38. |
2015
Hou, HH,Liao, YJ,Hsiao, SH,Shyue, SK,Lee, TS.
Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase
. Scientific report
.2015
;(5):13524
|
|
| 39. |
2015
Wu CH,Liao YJ,Shiau AC,Lin HY,Hsueh Liu YW,Hsu SM.
HDR Brachytherapy Dose Distribution is Influenced by the Metal Material of the Applicator
. Scientific report
.2015
|
|
| 40. |
2015
Lin YT,Yen CH,Chen HL,Liao YJ,Lin IF,Chen M, YC Lan, SY Chuang, SL Hsieh, YM Arthur Chen.
The serologic decoy receptor 3 (DcR3) levels are associated with slower disease progression in HIV-1/AIDS patients
. Journal of the Formosan Medical Association
.2015
;(114):498-503
|
|
| 41. |
2014
Wu CH,Shiau AC,Liao YJ,Lin HY,Liu YWH,Hsu SM.
Influence of Metal of the Applicator on the Dose Distribution during Brachytherapy
. PLOS ONE (10.1371/journal.pone.0104831)
.2014
|
|
| 42. |
2014
Wu CH,Liao YJ,Liu YWH,Hung SK,Lee MS,Hsu SM.
Dose Distributions of an 192Ir Brachytherapy Source in Different Media
. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (Article ID: 946213, 11 Pages)
.2014
|
|
| 43. |
2013
Chen YM,Liao YJ.
Phosphorylated forms of GNMT in mouse liver
. Journal of Proteomics
.2013
|
|
| 44. |
2013
Liao YJ,Lin MW,Yen CH,Lin YT,Wang CK,Huang SF, Chen KH, Yang CP, Chen TL, Hou MF, Arthur Chen YM..
Characterization of Niemann-Pick Type C2 Protein Expression in Multiple Cancers Using a Novel NPC2 Monoclonal Antibody
. PLoS One
.2013
;(8):1-11
|
|
| 45. |
2013
Lin IY,Yen CH,Liao YJ,Lin SE,Ma HP,Chan YJ, Chen YM.
Identification of FKBP11 as a biomarker for hepatocellular carcinoma
. Anticancer Res.
.2013
;(33):2763-2769
|
|
| 46. |
2012
Liao YJ,Chen TL,Lee TS,Wang CK,Liao LY,Wang HA, Liu RS, Huang SF, Lin CH, and Chen YM*.
Glycine N-methyltransferase deficiency affects Niemann-Pick Type C2 protein stability and regulates hepatic cholesterol homeostasis.
. Molecular Medicine
.2012
;(18):412-422
|
|
| 47. |
2012
Chen CY,Ching LC,Liao YJ,Yu YB,Tsou CY,Shyue SK, Chen YM* and Lee TS*.
Deficiency of glycine N-methyltransferase aggravates atherosclerosis in apolipoprotein E-null mice.
. Molecular Medicine
.2012
;(18):744-752
|
|
| 48. |
2012
Hsu SM,Wu CH,Lee JH,Hsieh YJ,Yu CY,Liao YJ, Kuo LC, Liang*JA, Huang David Y. C*.
A study on the dose distributions in various materials from an Ir-192 HDR brachytherapy source
. PLOS ONE
.2012
;(7):e44528-10
|
|
| 49. |
2011
Lee MS,Liao YJ,Huang YH,Lee JH,Hung SK,Chen TR, Hsu SM*.
Radiation characteristics of homemade radiophotoluminescent glass dosimeter
. Radiat. Meas.
.2011
;(46):1477-1479
|
|
| 50. |
2011
Liu SP,Li YS,Lee CM,Yen CH,Liao YJ,Huang SF, Chien CH, Chen YM*.
Higher susceptibility to aflatoxin B1-related hepatocellular carcinoma in glycine N-Methyltransferase knockout mice.
. Int. J. Cancer
.2011
;(128):511-523
|
|
| 51. |
2011
Hsu SM,Lee JH,Hsu FY,Lee HW,Hung SK,Liao YJ, Lee MS*.
Dose measurements for gamma knife with radiophotoluminescent glass dosimeter and radiochromic film
. Radiat. Prot. Dosim.
.2011
;(146):256-259
|
|
| 52. |
2010
Liao YJ,Chen KH,Huang SF,Chen TL,Wang CK,Chien CH, Tsai TF, Liu SP, Chen YM*.
Deficiency of glycine N-methyltransferase results in deterioration of cellular defense to stress in mouse liver
. Proteom. Clin. Appl.
.2010
;(4):394-406
|
|
| 53. |
2010
Hsu SM,Yang HW,Huang YH,Lee JH,Yu CY,Liao YJ, Hung SK, Lee MS*.
Chemical and physical characteristics of self-fabricated radiophotoluminescent glass dosimeter.
. Radiat. Meas.
.2010
;(45):553-555
|
|
| 54. |
2009
Liao YJ,Liu SP,Lee CM,Yen CH,Chuang PC,Chen CY, Tsai TF, Huang SF, Wu YH, Chen YM*.
Characterization of a glycine N-methyltransferase gene knockout mouse model for hepatocellular carcinoma
. Int. J. Cancer
.2009
;(124):816-826
|
|
| 55. |
2009
Chen YM,Liao YJ,Liu SP,Tsai TF.
Phenotypic differences of two GNMT-/- mouse model for hepatocellular carcinoma
. Hepatology
.2009
;(49):2130-2131
|
|